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Summary 
It is a common notion that mature B lymphocytes express either K  or X light (L) chains, although 
the mechanism that leads to such isotypic exclusion is still debated. We have investigated the 
extent of L chain isotypic exclusion in normal human peripheral blood B lyrnphocytes. By three- 
color staining with anti-CD19, anti-K, and anti-X antibodies we could estimate that 0.2-0.5% 
of peripheral blood B cells from healthy adults express both K and X on the cell surface. The 
K  +  X+ cells were sorted, immortalized by Epstein-Barr virus, and five independent clones were 
characterized in detail. All clones express both K and ~, on the cell surface and produce immuno- 
globulin M that contain both K  and ~ chains in the same molecule, i.e., hybrid antibodies. Sequencing 
of the L chains revealed in three out of five clones evidence for somatic mutations. It is interesting 
to note that among a panel of single receptor B cell clones we identified two X + clones  that 
carried a productively rearranged K, which was inactivated by a stop codon generated by somatic 
mutation. These findings indicate that dual receptor B lymphocytes can be found among mature 
antigen-selected B cells and suggest that somatic mutation can contribute to increase the degree 
of isotypic exclusion by inactivating a passenger,  nonselected L chain. 
I 
t is generally accepted  that mature B lymphocytes make 
. antibodies with one single type of L chain, either K or 
X (1, 2). In most cases, this isotypic exclusion is due to the 
fact that mature B cells express only one productively rear- 
ranged L chain gene. The mechanism responsible for this 
phenomenon has not been definitively established. An instruc- 
tive/regulated model proposes a precise order of L chain gene 
rearrangement starting at one chromosome, first at the K  and 
then at the ~ locus (3, 4). A stochastic model proposes that 
isotypic exclusion results from the high frequency of non- 
productive rearrangements and by a different recombination 
frequency of K and X loci (5,  6). 
In both cases, the termination of L chain genes rearrange- 
ment (coincident with downregulation of recombinant ac- 
tivating gene i [RAG1] and RAG2 gene expression) is medi- 
ated by the surface deposition of a complete Ig molecule (7-9). 
Although this is a necessary requirement, the production of 
a complete membrane (mlg) may not always be sufficient to 
terminate recombination. This may occur when the specificity 
of the antibody is inappropriate either because it is autoreac- 
five (10--12) or because it fails to promote positive selection (13). 
There are only few exceptions to the rule of isotypic ex- 
clusion. In humans, expression of both K and X chains on 
the same cell has been described in myelomas (14, 15), as well 
as in one EBV-transformed clone (16) and in one B cell line 
(17) isolated from fetal bone marrow, but not in the normal 
mature repertoire. 
Here we report that a small but discrete fraction of human 
peripheral blood B cells carries both K and X chains as part 
of the same Ig molecule and can undergo somatic hypermu- 
tation. Furthermore, in K+~,+B cells somatic mutations may 
increase the degree of isotypic exclusion by inactivating one 
of the two L chain genes. 
Materials and Methods 
FACS Staining and Isolation of  B Cell Clones.  PBMC  were stained 
with red 613-labeled anti CD19 (GIBCO BRL, Gaithersburg, MD), 
FITC-labeled anti-K  and PE-labeled anti-X (both from Dakopatts, 
Glostmp, Denmark). CD19+K+X  + sorted cells were immortalized 
in limiting dilution cultures in Terasaki plates. The medium was 
complete ILPMI 1640 containing 10% FCS, 30% supernatant of 
the EBV-produdng marmoset cell line B95.8, 30 I~g/ml of 90% 
saturated human transferrin, 500 ng/ml cyclosporin A, and 5  x 
10Vml irradiated (3,500 tad) allogeneic PBMC as feeder cells. 
After 3 wk the B cell clones were transferred to 96-weU plates in 
the presence of irradiated feeder cells and subsequently expanded 
in medium alone. The B cell clones were analyzed by two-color 
staining using FITC-conjugated F(ab)2 anti-K  and PE-conjugated 
F(ab)~ anti X (Southern Biotechnology Associates, Birmingham, 
AL). The DNA content of the B cell clones was determined as 
described (18). 
Detection of Ig and Hybrid Antibodies  by ELISA.  Polystyrene 
microplates (F-Form, Greiner, Frickenhausen,  Germany)  were coated 
overnight at 4~  with 5 #g/ml goat anti-human/~, y, K, or X 
(Southern  Biotechnology  Associates) in  carbonate-bicarbonate 
buffer, pH 9.6. The plates were washed with PBS and incubated 
at room temperature with saturation buffer (200 mM Tris-HC1, 
pH 7.5, containing 1% BSA). After 2 h the buffer was discarded 
and dilutions of the samples in PBS-1% FCS-0.2% Tween 20 were 
added for 2 h. The plates were washed and the alkaline phospha- 
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Figure  1.  Isolation  of r*~, + B 
cell clones from adult peripheral 
blood.  (.4) PBMC were stained 
with Red 613-labeled anti-CD19, 
FITC-hbded anti-x, and PE-hbeled 
anti-h. The dot plot shows the r/~, 
staining of the gated CD19 + cells. 
106 events were acquired. The sort- 
ing  gate is shown with the per- 
centage of  positive  cells. (B-G) K/h 
staining of EBV-B cell clones: (B) 
FSA 10 (IgGh); (C) 11.3 (IgGK); 
(D-G)  L47, F29, L32, and G28 
(IgMKX). 
tase-conjugated goat anti-human K, X, #, or 3' was added for 1 h. 
After a final wash the enzyme activity bound was determined using 
1 mg/ml p-nitrophenylphosphate in coating buffer. 
RT-PCRandDkectSequencingofVKandVA Chains.  TotalRNA 
was extracted from 1-3  x  106 cells as described (19) and reverse 
transcribed using oligo d(T) and avian myeloblastosis virus reverse 
transcriptase (Promega Corp., Madison, WI) in 30 #1 final volume. 
cDNA (1.5/~1) was PCR amplified in a thermocycler (model 9600; 
Perkin-Elmer Cetus, EmeryviUe, CA) using degenerate VK and VX 
oligonudeotides (kindly provided by Drs. Greg Winter and Ian 
Tomlinson, MRC Centre for Protein Engineering, Cambridge, U-K) 
and primers complementary to the CK and CX regions (20). The 
PCR profile was 2 rain at 94~  30 cycles at 940C for 15 s, 60~ 
for 20 s, 72~  for 35 s, and a final 10-min extension. The products 
were electrophoresed in 1.5% agarose gels and then allowed to enter 
in 0.7% NuSieve (FMC BioProducts, Rockland, ME). The product 
bands were excised, melted at 65~  and directly sequenced by the 
cycle sequencing method (Sequitherm; Epicentre Technols. Corp., 
Madison,  WI) with the same CK and CX oligonucleotides. 
Southern Blot Analysis.  High molecular weight genomic DNA 
was extracted from 5  x  106 cells. 8/~g DNA was digested with 
BamHI, electrophoresed through 0.8% agarose gel, transferred onto 
nylon filter (Hybond-N +; Amersham International, Amersham, 
Bucks, UK) and hybridized with a 3~P-labeled pHCK probe (2.7 
kb,  EcoRI; 20) according to the manufacturer's instructions. 
Sequencing of Gerraline VK Genes.  DNA was extracted from 
106 T cells and 0.5 #g was PCR amplified with oligonudeotides 
specific for the VgIV-subgroup member VKB3 (VrB3-5', GGC- 
TCTTGATTTACATTGGG; VKB3 Y, AAAGTATTAGGAAAG- 
TGCAC) and for the VrlI subgroup segment VrA3 (VxA3 5" 
AT'IGCTCACAGGAGAGACAT; VKA3 Y, CAGCACATGTGA- 
GCAACTGG). The products were purified and sequenced as above. 
Results 
Identification of e+A + B  Cells and Isolation of Clones that 
Produce  Hybrid Antibodies.  To identify B cells expressing both 
K and h proteins, PBMC were stained with FITC-labeled anti- 
K, PE-labded anti-h, and Red 613-1abded anti-CD19. Three- 
color analysis showed that a small proportion of the B ceils 
were stained by both anti-K and  anti-X (Fig.  1 A).  In five 
different  donors  tested,  the  proportion  of  K+X +  B  cells 
ranged  from 0.2  to 0.5%  of B  ceils in peripheral blood. 
K+X + B cells from three donors were sorted and immedi- 
ately cloned by limiting dilution in the presence of EBV. Trans- 
formed clones developed with low efficiency (1-5%), typical 
of EBV transformation. All five dories isolated expressed both 
K and X on the cell surface (Fig. 1, D-G). All the clones had 
a normal DNA content as detected by cytofluorimetric anal- 
ysis, thus excluding the possibility that they might have de- 
rived from  the fusion  of two B  cells (data  not  shown). 
The culture supernatant was tested by ELISA for the pres- 
ence of Ig H  and L chain determinants. All five K+X + clones 
produce IgM and both K and X L chains, although at different 
ratios (Fig.  2 A). In addition,  both g and X are present in 
the same Ig molecule, since the culture supernatants  gave a 
A  a  B 
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Figure 2.  K  +~ + B cell clones 
produce  hybrid antibody molecules. 
(.4) Amount of K (empty bars) and 
~, (b/ack bars) proteins in the culture 
supernatant of the various  clones as 
detected by ELISA using anti-lgM 
as a capturing  Ab and alkaline  phos- 
phatase-hbeled anti-r or anti-h. (B) 
Reactivity  of the supernatants in an 
ELISA assay  in which the capturing 
Ab is anti-K  and the developing  Ab 
is  anti-X. Dual  receptor clones: 
L47 (x), G28 (+), L32 (O), F29 
(A), and G21 (m). Single receptor 
clones: FSA10 (O) and G4 (A). sequences 
AI/A17  GATGTTGTGATGACTCAGTCT~CACTCT~CTGC~GTCAC~CTTGGACAGC~GGCCT~CATCTCCTGCAGGTCTAGTCAAAGCCT~GTATACAGT~T~~ 
L47  ..............................................................................................  C ......................... 
A$/A~7  TT~CAGCAGAGGCCAGGCCAATCTcCAAGGCGCCTAATTTATAAGGTT~CTAACTGGGACTCTGGGGT~cCAGACAGATTCAGC~~~A~TC 
L47  ......................................................  C ................................................................. 
A1/A17  AGCAGGGTGGAGGCTG~,GATGTrGGGGTTTATTACTGCATGCAAGGTACACACTGGCCTC  GTACACrI"ITGGCCAGGGGACCAAGCTGGAGATCAAACGT  C  Jr2) 
L47  ...........................  A .............  A ...................  A  .......................................  a 
A,?.7  GAAATrGTGTTGACGC-AGTCT~CAGGCAC~CTGTCTTTGTCT~CAGGGGAAAGAGcCAC~CTCTCCTGCAGGGC~A~A~~ 
F29  ........................................................................................................................ 
A27  CCTGGCCAGGCT~CAGGCT~CTCATCTATGGTGCAT~CAGCAGG~CCACTGGCAT~CAGACAGGTrCAGTGC~AGTGGGT~~T~ 
F29  ......................................................  G  .......................  C ......................................... 
A27  CCTGAAGAI"ITI"GCAGTGTATrACTGTCAGCAGTATGGTAGCTCACCT  GCTCACTTTCGGCGGAGGGtCCAAGGTGGAG~TCAAACGr  (J~c4) 
F29  ..............................................  GGGC  ...............  c ......................  -a 
02  GACATC  CAGATGACCCAGTCTCCATCCTCCCTGTCTGCATCTGTAGGAGACAGAGTCACCATCACTTGCCGGGCAAGTCAGA~~AT~ 
L3Z  ........................................................................................................................ 
02  GGGAAAGCCCCTAAGCTCCTGATCTATGCTGCAT~CAGTTTGCAAAGTGGGGTC~CATCAAGGTrCAGTGGCAGTGGATCT~~T~~ 
L3Z  .................................  -  ...................................................  - ........  g-G ...................... 
02  GAAGATITfGCAACTTACTACTGTCAACAGAGI"rACAGTACCCCT  ATrCACTTTCG~CCCGGGACCAAAGTGGATAT~GT  (J~c3) 
L32  .............................  CGGGAT  ...............  t  .......................  a 
B3  GACAT~GTGATGAC~CAGTCTCCAGACT~CTGGCTGTGTCTCTGGGCGAGAGGGCCA~CATCAACTGCAAGT~CAGCCAGAGT~ATA~T~~ 
G2~  ........................................................................................................................ 
B3  TGGTACCAGCAGAAACCAGGACAGCCTCCTAAGCTGCTCATTTACTGGGCATCTACCCGGGAATCCGGGGTCCCTGACCGATrCAGTGGCA~~~C  C 
G28  ........................................................................................................................ 
B3  ATCAGCAGCCTGCAGGCTGAA~TGTGGCAGTI~ATrACTGTCAGCAATAI"rATAGTACTCCT  GTACACITrTGGCCAGGGGACCAAGCTGGAGATCAAACGT  (J~2) 
G28  ...............................................................  TC  .......................................  o 
A3  GATATTGTGATGACTCAGTCTC  CACTCTCCCTGC  CCGTCACCCCTGGAGAGCCGGCCTCCATCTCCTGCAGGTCTAGTCAC~GCCTCCTGCATAGTAATGGATACAA~A~ 
G2Z  ........................................................................................................................ 
~ZSgl  ........................................................................................................................ 
RR2S  ............................................................................  A ................................  C----C-  --_M 
A3  TAC  CTGCAGAAGCCAGGGCAGTCT~CACAGCT~CTGATCTATTTGGGTFCTAAT~GGG~CT~GGGGT~CTGACAGG1~CAGTGGCA~T~~TC 
G21  ........................................................................................................................ 
RR2591  ........................................................................................................................ 
I~Z5  ....................................................  G  ......................  C .......................................  G .... 
A3  AGCAGAGTGGAGGCTGAGGATG'I-rGGGGTTTATTACTGCATGCAAGCTCTACAAACTCCT  TGTACACI"rTTGGC~CCAAC-CTGGAGATCAAACGT  (J~c2) 
G21  ..........................................................  TCA  ---G--G  ................................  -a 
~.5gl  ............................................................ 
RR25  -A- -- -A  ............  C ........................................  CC  .......................................  o 
B3  GACATCGTGATGACCCAGTCTCCAGACTCCCTGGCTGTGTCTCTGGGCGAGAGGGCCACCATC~ACTGCAAGTCCA~~TA~C~T~~ 
F~Zegt  ........................................................................................................................ 
Fs~ze  ................................................................................................  c  ....................... 
B3  TGGTACCAGCAGAAACCAGGACAGCCTcCTAAGCTGCTCAT1TACTGGGCATCTAcCCGGGAATC~GGGGT~CCTGAC~GATTCAGTGGCAGCGGGT~m~C 
FS~egt  ........................................................................................................................ 
FSAIB  -A- ..........  G .........  C .........  A-T ...................  A ................................................................ 
B3  ATCAGCAGCCTC~AGGCTGAAGATGTGGCAGITTAT[ACTGTCAGCAATATTATAGTACTCCT  GCTCACTTTCGGCGGAGGGACCAAGGTGGAGATCAAACGT  (3~'4) 
FSAI~gl  ............................................................... 
FSA~e  C-- -C- --A ...........  g .............  G  ...................  T ..............................................  o 
sequences 
VIII.I  TCCTATGAGCTGACTCAGCCACCCTCAGTGTCCGTGTCC  CCAGGACAGACAGCCAGCATCACCTGCTCTGGAGATAAATTGGGGGATJUkATAT~AT~~ 
L47  ........................................................................................................................ 
VIII.1  CAGTCCCCTGTGCTGGTCATCTATCAAGATAGCAAGC  GGCCCTCAGGGATCCCTGAGCGATTCTCTGGCTCCAACTCrGGGAACACA~CACTCTGAC~T~C~ATG 
L47  ................................  GG  ...................................................................................... 
VIII.  1  GATGAGGCTGACTATTACTGTCAGGCGTGGGACAGCAGCACTGCA  TATGTCTTCGG~ACTGGGACCAAGGTCACCGTCCTA  (J).l) 
L47  ..................................  A--A--  AT  ........  A ........................... 
TZC5  CAGTCTGTGTTGACGCAGCCGC  CCTCAGTGTCTGCGGCCCCAGGACAGAAGGTCACCATCTCCTGCTCTGGAAGCAGCTC~TM~AT~ATC~~C 
F29  ..........................................................................................  G- -CG  ......................... 
T2C5  ~CAGGAACAGC~UL~CT~CTCATTTATGACAATA~TAAGCGACcCTCAGGGATT~CTGA~GATTCTCT~~~T~a~G 
F29  ....................................................................  t  ................................................... 
T2C5  ACTGGGGACGAGGCCGATTATTACTGCGGAACATGGGATAGCAC~CTGAGTGCTGGT  GTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA  (J~Z/3) 
FZ9  ........................................  A ..................  g .............................. 
DPLI  CAGTCTGTGCTGACTCAGCCACCCTCGGTGTCTGAAGC  CCC  CAGGCAGAGGGTCACCATCTCCTGTTCTGGAAGCA~C~TC~T~T~AC~C 
L32  ....................  t  ............................  G .....  A----T  ................. 
I~PL1  CCAGGAAAGGCT~CCA~c~CTCCTCATCTATTATGATGATCTGCTGCCCTCAGGGGTCTCTGACCGA1TCTCTGGCTCCAAGT~C~(~CC~T~C~G 
L32  .......  C---c  ..................  AGGA- -A---A--G  .............  C ............................................................  G- 
DPL1  TCTGAGGATGAGGCTGATrATTACTGTGCAGCATGGGATGACAGCCTGAATGGT  GTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTA  (J~13) 
L32  --C ..............................................  CCC  --A-G .............................. 
VIIIb  TCCTATGAGCTGACACAGCCACCCTC  GGTGTCAGTGTCCCCAGGACAAACGGCCAGGATCACCTGCTCT~T~C~A~_E~T~A~~ 
G25  ...................................................................................................... 
VIIZb  CAGGCCCCTGTGCTGGTCATCTATAAGGACAGCAAACGAcCCTCAGGGAT~CCTGAGAGATTCTCT~C~T~C~T~C~G 
G28  ........................  G ...................  c .....................................................  t  ..................... 
VIIIb  GATG~AGATGACTACTACTGI-FACTCAGCAGACTACAGTGGTAATC  TGTGG~ATTCGGCGGAGGGACCAAGCTGACCGTCCTA  ($~/3) 
G28  .......  C ...................  A .....  AG  ...........  A  -AG---g  .............................. 
~PL16  TCTTCTGAGCTGACTCAGGAC  CCTGCTGTGTCTGTGGCCTTGGGACAGACAGTCAGGATCACATGCCAAGGAGA~A~AT~AC~~ 
G21  ........................................................................................................................ 
~PL16  CAGGC~CTGTACTTGTCATCTATGGT~A~-AA~GGC~CTCAG~GAT~cCAGACCGA~~~~T~~  ~ 
GZI  ........................................................................................................................ 
DPL16  GATGAGGCTGACTATTACTGTAACTCCCGGGACAGCAGTGGTAACCAT  TGTGGTA1TCGGCGGAGGGACCAAGCTGACCGTCCTA  (J ~/3) 
G21  ..............................................  TTTG  -- -g .............................. 
Figure  3.  Comparison between 
the L chain sequences of dual re- 
ceptor B cells and the corresponding 
germline genes. For each clone the 
K  and )~ sequences are shown start- 
ing from the beginning of FR1. The 
homologous germline V segment is 
shown in the upper line. Dashes in- 
dicate sequence identity. Replacing 
mutations are shown by uppercase 
letters. Stop codons are underlined. 
In all cases the sequences were rear- 
ranged in frame. Germline sequences 
are: K  locus, A1/A17 (25), A27 (26), 
02 (27), B3 (28), A3 (26), and Jg 
(29);)~  locus,  VIII.1  (30),  T2C5 
(3;), DPL1 (22), VIIIb (32) DPL16 
(22), and JX (29). In all the JK seg- 
ments used 0K 2, 3, and 4) we found 
one nucleotide  variation from the 
published sequences (29).  We did 
not consider this variation to be due 
to the hypermutation mechanism. 
To confirm  that  the stop  codons 
found in the VK of clones RR25 and 
FSA10 were somatically derived, the 
corresponding  germline VK  seg- 
ments were sequenced and are re- 
ported  as  RR25gl  and  FSA10gl. 
These  sequence data are available 
fi'om EMBL/GenBank/DDBJ under 
accession numbers Z46626, Z46634, 
Z46624, Z46622, Z46620, Z46616, 
Z46628, Z46615, 7_.,46619, Z46627, 
Z46618,  Z46625,  Z46623,  and 
Z46621,  respectively. 
positive signal in an ELISA assay in which the capturing an- 
tibody is anti-~c and the developing antibody anti-), (Fig. 2 B). 
Evidence for  Somatic  Mutations  in  ~c+~ +  B  Cells.  The 
K  +)`+  clones were analyzed by RT-PCR  using degenerate 
VK and V)` oligonucleotides followed by direct  sequencing 
from two independent PCR to minimize possible errors of 
the Taq polymerase.  In all cases, the direct sequences  of these 
products were unique,  indicating that only one K and one 
)` allele  were expressed  in each  clone. 
Since the human K locus has been extensively sequenced 
(21), it was possible to identify the corresponding germline 
gene and thus the potential somatic mutations. This was more 
problematic for the )` sequences,  since much less informa- 
tion is available (22-24). Three out of the five clones showed 
candidate mutations in both the VIC-JK and, possibly, in the 
V)`-J)` segments  (Fig.  3,  clones L47,  F29,  and L32).  One 
clone (F21)  had  a germline  VK and  V)`-J)`, but contained 
two mutations in the JIc2 segment.  The fifth clone (G28) 
1247  Giachino et al.  Brief Definitive Report Figure 4.  Clones FSA10 and RR25 carry one rearranged K allele. 
Southern blot analysis  with a CK probe on B cell clones FSA10 (IgG~,), 
Rtk25 (IgMX), and 11.3 (IgGK),  and a T cell  clone  (CO8.1) as a germline 
control. Note that the second  K allele  of both FSA10 and ILR25 clones 
is deleted. 
possessed a nonmutated K chain, whereas the V~ could not 
be clearly assigned. As already noticed, extra nucleotides were 
often present at the V-J junction and either could be due 
to an accumulation of mutations in the CDR3 or to addi- 
tions by TdT (Fig. 3). A very short VK-JK junction lacking 
four ainino acids were found in clone L32.  However, this 
K chain paired to the H chain and was expressed on the cell 
surface (Fig.  1 F). 
In summary, the sequences of K and X L chain genes in 
dual receptor B cells do not show any special features that 
may distinguish them from those expressed by single receptor 
B cells. Three out of five cases show a modest degree of so- 
matic mutation. 
Identification of A + B  Cells that Carry a Somatically Inacti- 
vated, but Otherwise  Functional K Chain Gen~  Because somatic 
mutations can cripple  Ig genes  one may expect  the dual 
K+~,  + B cells undergoing somatic hypermutation may often 
lose one VL gene and become single receptor cells. To look 
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for this possibility we analyzed by RT-PCR and sequencing 
a panel of 147 K  + or ~,+ B cell clones and identified two X+ 
clones (FSA10, IgGX and RR25, IgM~,) that carried an in- 
frame rearranged VK that was somatically hypermutated (Fig. 
3). Both VK genes involved (VKA3 and VKB3) were reported 
to be functional, but in these clones they were crippled by 
a mutation resulting in the substitution of tryptophane 35 
with a stop codon (Fig.  3). 
To rule out the possibility that the stop codons might rep- 
resent rare allelic variants  and not a somatic mutation event, 
the  corresponding  germline Vg  segments were  amplified 
and sequenced  from T  cell  lines  obtained from the  same 
donors from which the clones were isolated.  In both cases 
the results  confirmed the  somatic origin of the crippling 
mutation (Fig.  3). 
The  possibility that  the K sequences  were  due  to con- 
taminants of the clones was ruled out by two experiments. 
First, clones FSA10 and RR25 were subcloned and all sub- 
clones tested carried the same K message  (data not shown). 
Second, Southern blot analysis demonstrated that both FSA10 
and Rlk25  carry one rearranged K allele (Fig.  4). 
Discussion 
Our results demonstrate that a small fraction of human 
mature B cells express both K  and ~ and produce hybrid anti- 
bodies. This finding supports the stochastic versus regulated 
model of gene rearrangement. The fact that both in B and 
T  cells (33, 34) it is possible to find exceptions  to the "one 
cell one receptor" rule indicates that there are no specific  mech- 
anisms  that  prevent  the  generation and  selection  of dual 
receptor lymphocytes. 
What may be the origin of K+~,  + B cells? A first possi- 
bility is that a secondary ~  rearrangement took place as a 
consequence of receptor editing. In transgenic animal models 
it has been  shown that autoreactive B cells can edit their 
receptor by rearranging new VL genes (10-12).  However, 
receptor editing must lead to loss of the autoreactive receptor, 
due to preferential pairing of the new L chains or possibly 
deletion of K. Because in the dones described  here both K 
and ~  chains are expressed  on the cell surface, we tend to 
exclude receptor editing as an explanation for K  +  X+ B cells. 
A  second possibility is that in K+X + B cells the first L 
chain produced, although able to pair with the H chain, may 
have failed to terminate recombination, possibly because of 
failure  to induce positive selection  (13). 
A third and more likely possibility,  in the context of the 
stochastic model of Ig gene rearrangement, is that simultaneous 
rearrangements at both L chain loci may occur at low fre- 
quency and result,  in some cases, in the production of K  +  ~,+ 
B cells. This notion is supported by several published excep- 
tions to the K-X hierarchy of rearrangement (35-38) and by 
the finding of one K  + clone bearing an out-of-frame rear- 
ranged X allele and one ~,+ clone with both K alleles in germ 
line configuration (Giachino, C.,  unpublished data). 
Our analysis is limited to isotypic exclusion,  which is set 
to a large extent by the asynchronous rearrangement at the 
two L chain loci. We suggest that there will be also cases of dual receptor B cells generated by lack of allelic exclusion. 
These cases may actually be more frequent because of a more 
synchronous rearrangement of the two alldes at the same locus. 
An intriguing possibility is that dual receptor B cells can 
achieve isotypic exclusion as a consequence of somatic muta- 
tion leading to inactivation of the "passenger", i.e., nonselected 
L chain.  This possibility is dearly illustrated by the two )~+ 
clones that carry an otherwise functional Vx gene and that 
have been somatically  inactivated. 
We thank Klaus Karjalainen,  Ton Rolink, and Nicola Migone for critical reading and comments, and 
Greg Winter and Ian Tomlinson for providing oligonucleotides. 
The Basel Institute for Immunology was founded and is supported by F. Hoffmann-La Roche & Co. 
Ltd., Basel Switzerland. 
Address correspondence to Dr. C. Giachino, Dipartimento di Genetica Medica, Via Santena 19,  10126 
Torino, Italy. 
Received for publication  4  October 1994  and in revised form  18 November 1994. 
a~erelIces 
1.  Petals, B., G. Chiappino, A.S. Kdus, and P.G.H. Gell. qw 1965. 
Cellular localization of immunoglobulins with different allo- 
typic specificities  in  rabbit  lymphoid  tissues. J.  Exp. Med. 
122:853-863. 
2.  Bernier, G.M.,  and J.J.  Cebra.  1964.  Polypeptide chains  of 
human gamma-globulin:  cellular localization by fluorescent an- 
tibody. Science (Wash. DC).  144:1590-1592. 
3.  Hieter, P.A., S.J. Korsmeyer,  T.A. Waldmann, and P. Leder. 
1981. Human immunoglobulin K  light-chain genes are deleted 
or rearranged in  h-producing B  cells.  Nature (Lond.). 290: 
368-372. 
4.  Korsmeyer,  S., P. Hieter, S. Sharrow,  C. Goldman, P. Leder, 
and T. Waldmann.  1982.  Normal human B cells display or- 
dered rearrangements and deletions.J. Ext~ Med. 156:975-985. 
5.  Coleclough, C., R.P. Perry, K. Karjalainen,  and M. Weigert. 
1981. Aberrant rearrangements contribute significantly to the 
allelic exclusion  of immunoglobulin gene expression.  Nature 
(Lond.). 290:372-378. 
6.  Ramsden,  D.A.,  and G.E.  Wu.  1991. Mouse  ~ light-chain 
recombination signal sequences mediate recombination more 
frequently than do those of ~  light chain. Proc. Natl. Acad. 
Sci. USA.  88:10721-10725. 
7.  Manz,J., K. Denis, O. Witte, R. Binster, and U. Storb.  1988. 
Feedback inhibition of immunoglobulin gene rearrangement 
by membrane #  but not by secreted #  heavy chains. J. Exp. 
Med, 168:1363-1381. 
8.  Ritchie, K.A., R.L. Brinster, and U. Storb. 1984. Allelic ex- 
clusion and control of endogenous immunoglobulin gene re- 
arrangement in kappa  transgenic mice. Nature (Lond.). 312: 
517-520. 
9.  Storb, U. 1987. Transgenic mice with immunoglobulin genes. 
Annu.  Rev. Immunol. 5:151-174. 
10.  Gay,  D.,  T.  Saunders,  S.  Camper,  and  M.  Weigert.  1993. 
Receptor editing: an approach by autoreactive B cells to es- 
cape tolerance. J. Exl~ ivied. 177:999-1008. 
11.  Tiegs, S.L., D.M. Russell,  and D. Nemazee. 1993. Receptor 
editing in  self-reactive  bone marrow  B  cells. J.  Exp. Med. 
177:1009-1020. 
12.  Radic,  M.Z., J. Erikson, S. Litwin, and M. Weigert.  1993. 
B lymphocytes may escape tolerance by revising their antigen 
receptors. J. Exi~ Med. 177:1165-1173. 
13.  Rolink, A., U. Grawunder, D. Haasner,  A. Strasser, and F. 
Melchers.  1993. Immature surface Ig § B cells can continue 
to rearrange kappa and lambda L chain gene loci.J. Exp. Med. 
178:1263-1270. 
14.  Bouvet, J.P., D. Buffe, R. Oriol, and P. Liacopoulos.  1974. 
Two myeloma globulins, IgGl-lc and IgG1-)~, from a single 
patient (Im). Immunology. 27:1095-1101. 
15.  Hopper, J.E. 1977. Comparative studies on monotypic IgM~, 
and IgGg from an individual patient. IV. Immunofluorescent 
evidence for a common clonal synthesis.  Blood. 50:203-211. 
16.  Cuisinier, A.-M., F. Fumoux, M. Fougereau, and C. Tonnelle. 
1992.  IgMx/X  EBV human  B cell clone:  an  early step  of 
differentiation of fetal B cells or a distinct B lineage? Mol. Im- 
munol. 29:1363-1373. 
17.  Pauza, M.E., J.A. Rehmann, and T.W. LeBien. 1993. Unusual 
patterns of immunoglobulin gene rearrangement and expres- 
sion during human B cell ontogeny: human B cells can simul- 
taneously express cell surface ic and )~ light chains.J. Exp. Med. 
178:139-149. 
18.  Windelov, L.L., I.J.  Christensen, and N.I. Nissen.  1983. A 
detergent-tripsin method for the preparation of nuclei for flow 
cytometric DNA analysis. Cytometry. 3:323-326. 
19.  Chomczynski, P., and N. Sacchi.  1987. Single-step  method 
of RNA isolation by acidic guanidinium thiocyanate-phenol- 
chloroform extraction. Anal. Biochem. 162:156-159. 
20.  Foa, R., G. Casorati, M.C. Giubellino, G. Basso, R. Schir6, 
G. Pizzolo, F. Luria, M.-P.  Lefranc,  T.H. Rabbitts,  and N. 
Migone. 1987. Rearrangements ofimmunoglobulin and T cell 
receptor/3 and 3/genes  are associated  with  terminal deox- 
ynucleotidyl transferase expression in acute myeloid leukemia. 
J. Exp. Med. 165:879-890. 
21.  Schable, K.F., and H.-G. Zachau.  1993.  The variable genes 
of the human immunoglobulin K locus. Biol. Chem. Hoppe. 
Seyler. 374:1001-1013. 
22.  Williams,  S.C., and G. Winter. 1993. Cloning and sequencing 
of human immunoglobulin V lambda gene segments.  Eur. J. 
Immunol. 23:1456-1461. 
23.  Chuchana,  P.,  A.  Blancher,  F.  Brockly, D.  Alexandre,  G. 
Lefranc, and M.-P. Lefranc. 1990. Definition of the human ira- 
1249  Giachino  et al.  Brief Definitive Report munoglobulin variable lambda (IGVL) gene subgroup. Eur.  J. 
Immunol. 20:1317-1325. 
24.  Winkler, T.H., H. Fehr, and J.K. Kalden. 1992. Analysis of 
immunoglobulin variable region genes from human IgG anti- 
DNA hybridomas. Eur. j. Immunot. 22:1719-1728. 
25.  Lautner-lkieske, A., C. Huber, A. Meindl, W. Pargent, K.F. 
Schaeble, K. Thiebe, I.A. Zocher, and H.G. Zachau. 1992. The 
human immunoglobulin kappa locus. Characterization of the 
duplicated A regions. Eur. J. Immunol. 22:1023-1029. 
26.  Straubinger, B,, E. Huber, W. Lorenz, E. Osterholzer, W. Par- 
gent, M. Pech, H.D. Pohlenz, F.J. Zimmer, and H.G. Zachau. 
1988. The human VK locus: characterization of a duplicated 
region encoding 28 different immunoglobulin  genes. J. MoI. 
Biol. 199:23-32. 
27.  Pargent,  W.,  A.  Meindl,  K.  Thiebe,  S.  Mitzel,  and H.G. 
Zachau. 1991. The human immunoglobulin kappa locus. Char- 
acterization  of the duplicated  O  region.  Eur. J.  Immunol. 
21:1821-1827. 
28.  Klobeck, H.G., G.W. Bomkamm, G. Combriato, K. Mocikat, 
H.D. Pohlenz, and H.G. Zachau. 1988. Subgroup IV of  human 
immunoglobulin  K light chains is encoded by a single germ- 
line gene. Nucleic Acid Res. 13:6515-6521. 
29.  Kabat, E.A., T.T. Wu, M. Reid-Miller, H.M. Perry, and K,S. 
Gottesman. 1991. Sequences  of proteins of immunological in- 
terest.  US  Government  Printing  Office, Bethesda, MD. 
165-462. 
30.  Combriato, G., and H.G. Klobeck. 1991. Vlambda andJlambda- 
Clambda gene segments of  the human immunoglobulin lambda 
light chain locus are separated by 14Kb and rearrange by a de- 
letion mechanism. Eur. J. Immunol. 21:1513-1522. 
31.  Berinstein, N., S. Levy, and R. Levy. 1989. Activation of an 
excluded immunoglobulin allele in a human B lymphoma cell 
line. Science (Wash. DC). 244:337-339. 
32.  Fang, Q.,  C.C.  Kannapell, F.  Gaskin,  A.  Solomon,  W.J. 
Koopman, and S. Fu. 1994. Human rheumatoid factors with 
restrictive specificity  for rabbit IgG: auto- and multi-reactivity, 
diverse V~ gene segment usage and preferential usage of V￿ 
1111o. J. Extx Med. 179:1445-1456. 
33.  Padovan,  E., G. Casorati, P. DeUabona, S. Meyer,  M. Brockhaus, 
and A. Lanzavecchia. 1993. Expression of two T cell receptor 
alpha  chains: dual  receptor  T  cells, Science (Wash. DC). 
262:422-424. 
34.  Davodeau, F., M.A. Peyrat, I. Houde, M.M. Hallet, L.G. De, 
H. Vie, and M. Bonneville. 1993. Surface expression of two 
distinct functional antigen receptors on human gamma delta 
T cells. Science (Wash. DC). 260:1800-1802. 
35.  Berg, J., M. McDowell, H.-M. Jack, and M. Wabl. 1990. Im- 
munoglobulin )x gene rearrangement can precede K  gene rear- 
rangement.  Dev. Immunol. 1:53-56. 
36.  Felsher, D.W., D.T. Ando, and J. Braun.  1991. Independent 
rearrangement of Ig )x genes in tissue culture-derived murine 
B cell lines. Int. lmmunol. 3:711-718. 
37.  Tang,  J.-Q., M.C. Bene, and G.C. Faure. 1991. Alternative rear- 
rangements of immunoglobulin  light chain genes in human 
leukemia. Leukemia (Baltimore). 5:651-656. 
38.  Beishuizen,  A., K. Hahlen, A. Hagemeijer,  M.-A.J. Verhoeven, 
H. Hooijkaas, H.J. Adriaansen, I.L.M. Wolvers-Tettero,  E.K. 
van Wering, andJ.J.M, van Dongen. 1991. Multiple rearranged 
immunoglobulin  genes  in  childhood  acute  lymphoblastic 
leukemia  of precursor  B-cell origin.  Leukemia (Baltimore). 
5:657-661. 
1250  Dual Receptor  B Cells 